PROGENICS PHARMACEUTICALS (PGNX) Covered Calls

PROGENICS PHARMACEUTICALS covered calls Progenics Pharmaceuticals, Inc. is a biopharmaceutical company, which develops and commercializes innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.

You can sell covered calls on PROGENICS PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PGNX (prices last updated Fri 4:16 PM ET):

PROGENICS PHARMACEUTICALS (PGNX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
7.81 -0.08 7.76 7.84 1.3M - 0.7B
Covered Calls For PROGENICS PHARMACEUTICALS (PGNX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 8 0.40 7.44 5.4% 54.8%
Nov 16 8 0.90 6.94 13.0% 51.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Progenics Pharmaceuticals, Inc. engages in developing medicines for oncology. It offers clinical trials of product candidates for prostate cancer, and resumed a pivotal trial of an ultra-orphan radiotherapy candidate for pheochromocytoma. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in Tarrytown, NY.